Common Equity: The sum of all common equity items.
Oncolytics Biotech Inc. (ONCY) had Common Equity of $-3.80M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-9.19M |
|
-- |
|
-- |
|
$9.68M |
|
$-9.68M |
|
$0.69M |
|
$-8.99M |
|
$-8.99M |
|
$-9.19M |
|
$-9.19M |
|
$-9.19M |
|
$-9.19M |
|
$-9.68M |
|
$-9.82M |
|
95.86M |
|
95.86M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$6.84M |
|
$0.23M |
|
$0.74M |
|
$7.58M |
|
$6.10M |
|
-- |
|
$5.28M |
|
$11.38M |
|
|
Common Equity |
$-3.80M |
$-3.80M |
|
$-3.80M |
|
108.02M |
|
| Cash Flow Statement Financials | |
$-20.11M |
|
$-0.01M |
|
$14.12M |
|
$11.08M |
|
$5.20M |
|
$-5.88M |
|
$3.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
241.96% |
|
241.96% |
|
-121.23% |
|
241.96% |
|
$-0.04 |
|
$-0.21 |
|
$-0.21 |
|